Products / Services
  • Products / Services
  • Companies
  • Buy Leads
    Post Buy Requirement

    PAMIDRONATE DISODIUM IV INFUSION BP 30 MG & 60 MG

    • StorageCool and Dry Place
    • Dosage5mg
    • Grade StandardMedicine Grade
    • CATEGORYOncology Injectionables
    • Supply TypeManufacturer, Exporter, Supplier, Retailer
    • Preferred Buyer Location All over the world
    View More Details
    Send Enquiry

    Company Information

    location Kandivali East, Mumbai, Maharashtra
    View Number
    • calendar Member Since 14 Years
    • building Nature of Business Retailer
    • gst icon GST No. 27AAHPM3187H1ZG

    Ask for more detail from the seller

    Contact Supplier
    Report incorrect details
    • Product Details

    • Company Details

    no_img_icon

    • Grade StandardMedicine Grade
    • Packaging TypePlastic Bottle
    • UsageClinical, hospital etc.
    • CATEGORYOncology Injectionables
    • StorageCool and Dry Place
    • StorageCool and Dry Place
    • Dosage5mg
    • FormTablets / Liquid / Capsules / Powder

    Pamidronate Disodium  IV Infusion BP 30 mg & 60 mg is used in  treatment of moderate to severe hypercalcemia associated with malignancy with or without bone metastases; treatment of moderate to severe Paget disease of bone; treatment of osteolytic bone lesions of multiple myeloma and bone metastases of breast cancer in conjunction with standard chemotherapy.

    3s corporation is Supplier,Exporter ,Wholesaler  for Pamidronate Disodium  IV Infusion BP 30 mg & 60 mg in India.

    India has many manufacturers who manufacture Pamidronate Disodium  IV Infusion BP 30 mg & 60 mg .To know more contact us.

     

     

    ADDITIONAL INFORMATION

    Moderate to Severe Hypercalcemia of Malignancy
    Adults

    IV For moderate, give 60 to 90 mg as an initial single-dose infusion over 2 to 24 h. For severe, give 90 mg as an initial single-dose infusion over 2 to 24 h. For retreatment, same as initial therapy, at least 7 days after initial dose.

    Paget Disease
    Adults

    IV 30 mg/day as a 4-h infusion on 3 consecutive days for a total dose of 90 mg. For retreatment, same as initial therapy, when clinically indicated.

    Osteolytic Bone Metastases of Breast Cancer
    Adults

    IV 90 mg as a 2-h infusion every 3 to 4 wk.

    Osteolytic Bone Lesions of Multiple Myeloma
    Adults

    IV 90 mg as a 4-h infusion on a monthly basis.

     

    SIDE EFFECTS
    CARDIOVASCULAR

    Atrial fibrillation; atrial flutter; cardiac failure; hypertension; syncope; tachycardia.

    CNS

    Asthenia; anxiety; fatigue; headache; insomnia; paresthesia; psychosis; somnolence.

    DERMATOLOGIC

    Sweating.

    ENDOCRINE

    Hypothyroidism.

    GI

    Abdominal pain; anorexia; constipation; diarrhea; dyspepsia; GI hemorrhage; nausea; stomatitis; vomiting.

    GENITOURINARY

    UTI; uremia; renal toxicity.

    HEMATOLOGIC-LYMPHATIC

    Anemia; granulocytopenia; leukopenia; neutropenia; thrombocytopenia.

    LAB TESTS

    Hypocalcemia; hypokalemia; hypomagnesemia; hypophosphatemia.

    LOCAL

    Infusion-site reaction.

    MUSCULOSKELETAL

    Arthralgia; arthrosis; back pain; bone pain; musculoskeletal pain; myalgia; osteonecrosis primarily of the jaws.

    RESPIRATORY

    Coughing; dyspnea; pleural effusion; rales; rhinitis; sinusitis; upper respiratory infection.

    MISCELLANEOUS

    Edema; fever; metastases; moniliasis; pain; allergic manifestations (eg, hypotension, dyspnea, angioedema, anaphylactic shock) .


    Interested in this product? Ask for more details & Latest Price from seller
    Send Enquiry
    Share your requirements for a quick response!
    Tell us what you need?

    By clicking Get Quotes Now, I accept the T&C and Privacy Policy.

    Looking for PAMIDRONATE DISODIUM IV INFUSION BP 30 MG & 60 MG?

    Quantity
    Seller Contact Details
    Waiting for permission
    To search by voice, go to your browser settings and allow access to microphone

    Allow microphone access to search with voice